Home
>
National Drug Code (NDC)
>
Metoclopramide
Metoclopramide - 76045-101-20 - (Metoclopramide Hydrochloride)
Drug Information of Metoclopramide
| Product NDC: | 76045-101 |
| Proprietary Name: | Metoclopramide |
| Non Proprietary Name: | Metoclopramide Hydrochloride |
| Active Ingredient(s): | 10 mg/2mL & nbsp; Metoclopramide Hydrochloride |
| Administration Route(s): | INTRAVENOUS |
| Dosage Form(s): | INJECTION, SOLUTION |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Metoclopramide
| Product NDC: | 76045-101 |
| Labeler Name: | BD Rx Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA091392 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20130503 |
Package Information of Metoclopramide
| Package NDC: | 76045-101-20 |
| Package Description: | 24 BLISTER PACK in 1 CARTON (76045-101-20) > 1 SYRINGE, GLASS in 1 BLISTER PACK > 2 mL in 1 SYRINGE, GLASS |
NDC Information of Metoclopramide
| NDC Code | 76045-101-20 |
| Proprietary Name | Metoclopramide |
| Package Description | 24 BLISTER PACK in 1 CARTON (76045-101-20) > 1 SYRINGE, GLASS in 1 BLISTER PACK > 2 mL in 1 SYRINGE, GLASS |
| Product NDC | 76045-101 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Metoclopramide Hydrochloride |
| Dosage Form Name | INJECTION, SOLUTION |
| Route Name | INTRAVENOUS |
| Start Marketing Date | 20130503 |
| Marketing Category Name | ANDA |
| Labeler Name | BD Rx Inc. |
| Substance Name | METOCLOPRAMIDE HYDROCHLORIDE |
| Strength Number | 10 |
| Strength Unit | mg/2mL |
| Pharmaceutical Classes | Dopamine D2 Antagonists [MoA],Dopamine-2 Receptor Antagonist [EPC] |
